Israeli cybersecurity unicorn Claroty has raised $400 million in a Series E round led by SoftBank’s Vision Fund 2. The new funds will be used to buy Israeli startup Medigate that specializes in medical infrastructure security. Yossi Cohen, the head of SoftBank’s financial advisors and a former Mossad chief, will join the Claroty board.
Claroty’s total funding now stands at $635 million after this round. Medigate’s acquisition will involve both cash and stock.
Claroty’s Series E investment also included current investors Bessemer Venture Partners and Schneider Electric, as well as Rockwell Automation.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at firstname.lastname@example.org.
Founded in 2015 by Amir Zilberstein, Benny Porat, and Galina Antova, Claroty raised $140 million in a Series D round in June, valuing the company at $1 billion.
“As digital transformation initiatives drive the essential physical systems that we rely on for even the most basic human needs, securing these systems is ultimately about mitigating risks to human life,” said Yossi Cohen of SoftBank Investment Advisers. “Claroty’s technology addresses a high-stakes problem in enabling safe digital transformation, and we are eager to partner with the team in its journey to protect the critical infrastructure that is the foundation of the AI revolution.”
According to Forbes, the company was valued at close to $2 billion in the Series E. Calroty CEO Yaniv Vardi told Calcalist “our revenue has more than doubled. We haven’t yet surpassed $100 million in yearly revenue, but we are doubling our earnings every year. We’ll be close to that figure now that Medigate has joined us, and we’ll be closer to going public.”
Medigate’s most recent funding round was a $30 million Series B in September 2020. Partech Partners, a new investor, led the round which included previous investors YL Ventures, U.S. Venture Partners, and Blumberg Capital, as well as first-time investor Maor Investments.
Medigate’s solution addresses patient safety and privacy by automatically locating, identifying, and managing the security posture of all devices connected to the network, as well as powering clinical engineering with device data.
The company was founded in 2017 by Jonathan Langer (CEO), Itay Kirshenbaum (VP R&D), and Pini Pinhasov (VP Product).
The industry’s first dedicated healthcare IoT security platform, which was named 2021 Best in KLAS for Healthcare IoT Security in the KLAS Software & Services Report,” said Jonathan Langer, co-founder and CEO of Medigate.
“Becoming a part of Claroty means our customers will not only continue to receive the best security for their healthcare IoT devices”, Langer added, “but will also gain coverage for the wide array of industrial IoT assets in their networks, without having to stitch together disparate tools for each.”